Clevidipine Butyrate

CAS 167221-71-8 3 current recordsSmall Molecule

Who holds supplier records for Clevidipine Butyrate? 3 organisations hold a current record for Clevidipine Butyrate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: Spain (1) and India (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Clevidipine Butyrate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/clevidipine-butyrate

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Clevidipine Butyrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Spain1India1Country not recorded for 1
  • ALP PHARM BEIJING CO LTD
    Active DMF 29850 · latest filing Aug 2016
  • INKE SA
    Active DMF 36436 · latest filing Jun 2022
    Spain
  • MSN Laboratories Private Limited
    Active DMF 34634 · latest filing Feb 2020
    India Company GMP cert on record
Need Clevidipine Butyrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Clevidipine Butyrate is a calcium channel blocker used mainly to reduce blood pressure quickly in hypertensive emergencies. It is administered intravenously and is characterized by its ultrashort-acting nature.

Chemical identity

IUPAC name
5-O-(butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
Canonical SMILES
CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
InChIKey
KPBZROQVTHLCDU-UHFFFAOYSA-N
Synonyms
Cleviprex API, clevidepine, clevidepine butyrate, clevidipine, cleviprex, h-324/38, h324/38

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Dihydropyridine Calcium Channel Blocker
Mechanism of action
Calcium Channel Antagonists
Chemical structure
Dihydropyridines

Therapeutic areas

CardiovascularHypertension

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Clevidipine Butyrate?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Clevidipine Butyrate: ALP PHARM BEIJING CO LTD, INKE SA (Spain) and MSN Laboratories Private Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Clevidipine Butyrate Drug Master Files are active?

ALP PHARM BEIJING CO LTD (DMF 29850), INKE SA (DMF 36436) and MSN Laboratories Private Limited (DMF 34634). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Clevidipine Butyrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Clevidipine Butyrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.